This epidemic is a recurring headline, and it’s killing more than 115 people a day in the US. Our healthcare system is in a frenzy to find an effective solution to halt the opioid crisis that has taken our nation by storm.
On this dark, dismal path of opioid abuse, dependence, and addiction, exists a bright light we refer to as Neuromodulation—an FDA approved medical technology that’s been effectively used since the 1990s to treat chronic pain, epilepsy, Parkinson’s, chronic headaches, and, more recently, sleep apnea, depression, and substance abuse. Neuromodulation is the fastest growing space in healthcare with a massive surge in spending, increasing from $1.5 billion to $3.7 billion over the last 5 years. The capabilities of this technology are colossal as resources are continuously poured into its further advancement and evolving functionality.
These discreet, implantable neural devices have the powerful capability of intervening in the adoption of addiction by confronting the root of the cause—PAIN. Even more remarkable is the ability of this technology to integrate with the consumer’s daily routines and interact with the world of IoT, the network where we are exchanging data between the industry’s greatest technology like wearables, voice tech and more.
We’ve convened an impressive power panel including the four largest global medical device enterprises, as well as the North American Neuromodulation Society whose mission is to promote collaboration across multiple disciplines. Together they will engage us in a provocative and inspiring conversation on how this proven solution is poised to make an everlasting impact in this medical emergency.